Hospital-acquired
pneumonia also called as healthcare associated pneumonia or
nosocomial pneumonia is acquired in hospital premises. Unlike
community acquired pneumonia hospital acquired pneumonia is mainly
caused due to multidrug resistant microorganisms. The report analyzes
the market for late stage candidates for treatment of nosocomial
pneumonia, and also provides a detailed review of drugs in early
stages of clinical trials. The report studies and estimates market
for six late stage along with an elucidation of ten early stage
candidates for nosocomial pneumonia treatment.
Browse
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market
Report with Full TOC at
http://www.transparencymarketresearch.com/hospital-acquired-pneumonia-drugs.html
Phase
III candidates include tedizolid phosphate, ceftolozane/tazobactam,
ceftazidime/avibactam, amikacin inhale, plazomicin and synflorix
vaccine. Market for each of the investigational drugs is estimated
based on current anti-microbial efficiency, historic market trend and
patents of drugs from similar class, manufacturing and marketing
licenses, along with competition from commercialized and pipeline
drugs. Hospital acquired pneumonia drugs market for phase III
candidates has been estimated from the expected year of launch till
2020. The hospital acquired pneumonia drugs market report also gives
a brief review of the various drugs commercially available for
treating hospital acquired pneumonia. Historic market revenue of
these drugs from 2011 to 2013 has also been included. Market forecast
mainly rests on a detailed event impact analysis, which considers
historic as well as anticipated events which impact the market in
varying degrees.
Global
market for hospital acquired pneumonia drugs is mainly driven by the
increasing prevalence of nosocomial infections across the globe. To
illustrate this fact, the report includes a statistical comparison of
the prevalence of nosocomial infections in various developed and
developing countries. Geographical trend of hospital acquired
pneumonia drugs market, is explains with a brief regulatory approval
process, along with expected time frame for drug launch in various
countries. These trends have been explained for geographical regions
including North America, Europe, Asia Pacific and Rest of the World.
Request
for customization of this report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1881
To
gain a complete market understanding, Porters Five Force’s
analysis, and value chain analysis has also been included in the
hospital acquired pneumonia drugs market report. The report also
explains key market drivers, restraints, opportunities in the
hospital acquired pneumonia drugs market. Diagnosis, treatment, and
epidemiology of hospital acquired pneumonia gives a clinical overview
of the disease and current modes of disease management. Relevant
recommendations have been suggested for designing successful market
strategies for competing in the market.
Browse
all Press Releases:
http://www.transparencymarketresearch.com/press-releases.htm
Hospital
acquired pneumonia drugs market report also includes company profiles
of key market players. These include Achaogen, Inc., Aridis
Pharmaceuticals, AstraZeneca plc, Cubist Pharmaceuticals, Inc., Meiji
Seika Pharma Co. Ltd., Merck & Co. Ltd., Sanofi, GlaxoSmithKline,
Inc., and Valneva SE. All of these players are profiled considering
company overview, financial overview, product portfolio, business
strategies, and recent developments.
Browse
all Article :
http://www.transparencymarketresearch.com/articles.htm
Browse
Consumer Goods Market Research Reports @
http://www.transparencymarketresearch.com/consumer-goods-market-reports-7.html
About
Us
Transparency
Market Research (TMR) is a market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. TMR's
experienced team of Analysts, Researchers, and Consultants, use
proprietary data sources and various tools and techniques to gather
and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Ms.
Sheela AK
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
No comments:
Post a Comment